FOXO3 and metabolic dysfunction-associated steatotic liver disease: Collectively, our results demonstrated that miR-122-5p was a potential mediator to contribute to hepatic inflammatory and oxidative stress response through inhibiting FOXO3 in the development of NAFLD.